Clinical Trials
Psychedelic-Assisted Clinical Trials at Pacific Neuroscience Institute
Our clinical trials work at TRIP is aiming to help develop novel psychedelic therapies and advance psychedelic medicines including psilocybin, LSD derivatives, 5-MeO-DMT and MDMA towards FDA approval.
We will continue conducting clinical trials for conditions such as depression, anxiety, addiction and grief. In the future, we plan to expand our focus to trials in patients with brain injury and neurodegenerative conditions such as traumatic brain injury (TBI), stroke, mild cognitive impairment, dementia, and pain syndromes. It is in these areas where the neuroplasticity-promoting effects of psychedelics may be “game-changers” in helping to restore cognitive function, halt further deterioration and ultimately improve quality of life.
Clinic: 1301 20th St #540, Santa Monica, CA 90404 | 310-582-7611
Open Trials
Completed Trials

Generalized Anxiety Disorder
A Dose-Finding Study of MM-120 (LSD D-Tartrate) for the Treatment of Anxiety Symptoms:
Multi-site trial. Completed enrollment of 15 patients. Sponsor: MindMed
Start Up Phase Trials

Brain Tumor Distress
Pilot trial of psilocybin-assisted therapy for psychiatric distress in patients with brain tumors (Investigator-Initiated Trial):
To assess feasibility and safety of psilocybin-assisted therapy in patients with brain tumors. Enrollment Winter 2023
Videos about Psychedelic-Assisted Therapy












Meet Dr. Heinzerling

Psychedelic-Assisted Therapy at Pacific Neuroscience Institute

Helping Patients and Advancing Science With a Psilocybin Trial | Karina Sergi, MS, MFT

39. A Life-Changing Clinical Trial with Psychedelics | Vikki’s Grateful Patient Story

The Promise of Psychedelics | Dr. Keith Heinzerling & Louie Schwartzberg

Healing with Visual Art, Music & Mushrooms with Louie Schwartzberg (ft. Deepak Chopra & Dr. Dan Kelly) | Fungi Global Summit

Brain Injuries and Psychedelics

Psychedelics Renaissance | Dr. Daniel Kelly

Treatment & Research In Psychedelics (TRIP) at Pacific Neuroscience Institute | Explainer

NBC News Features Treatment & Research In Psychedelics (TRIP) Program at PNI

Psychedelic-Assisted Therapy: A New Dawn for Mental Health | Daniel Kelly, MD
Articles about psychedelic-assisted therapy
If you or someone you know is in crisis, call the National Suicide Prevention Lifeline (Lifeline) at 1-800-273-TALK (8255), or text the Crisis Text Line (text HELLO to 741741). Both services are free and available 24 hours a day, seven days a week. The deaf and hard of hearing can contact the Lifeline via TTY at 1-800-799-4889. All calls are confidential. Contact social media outlets directly if you are concerned about a friend’s social media updates or dial 911 in an emergency. Learn more on the Lifeline’s website or the Crisis Text Line’s website.

For more information about treatment and research studies at the TRIP program please contact Dr. Heinzerling.
Virtual Video Visits Are Available
Our specialists have consultation openings for new patients anywhere in California.
Treatment with Ketamine: 310-582-7612
Clinical Trials: 310-582-7611